BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35271622)

  • 1. Implementation of rapid and frequent SARS-CoV2 antigen testing and response in congregate homeless shelters.
    Aranda-Díaz A; Imbert E; Strieff S; Graham-Squire D; Evans JL; Moore J; McFarland W; Fuchs J; Handley MA; Kushel M
    PLoS One; 2022; 17(3):e0264929. PubMed ID: 35271622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of infection control strategies to reduce COVID-19 outbreaks in homeless shelters in the United States: a simulation study.
    Chapman LAC; Kushel M; Cox SN; Scarborough A; Cawley C; Nguyen TQ; Rodriguez-Barraquer I; Greenhouse B; Imbert E; Lo NC
    BMC Med; 2021 May; 19(1):116. PubMed ID: 33962621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with SARS-CoV-2 positivity in 20 homeless shelters in Toronto, Canada, from April to July 2020: a repeated cross-sectional study.
    Kiran T; Craig-Neil A; Das P; Lockwood J; Wang R; Nathanielsz N; Rosenthal E; Snider C; Hwang SW
    CMAJ Open; 2021; 9(1):E302-E308. PubMed ID: 33785478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandemic Planning in Homeless Shelters: A Pilot Study of a Coronavirus Disease 2019 (COVID-19) Testing and Support Program to Mitigate the Risk of COVID-19 Outbreaks in Congregate Settings.
    O'Shea T; Bodkin C; Mokashi V; Beal K; Wiwcharuk J; Lennox R; Guenter D; Smieja M; Bulir D; Chong S
    Clin Infect Dis; 2021 May; 72(9):1639-1641. PubMed ID: 32511704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters - Four U.S. Cities, March 27-April 15, 2020.
    Mosites E; Parker EM; Clarke KEN; Gaeta JM; Baggett TP; Imbert E; Sankaran M; Scarborough A; Huster K; Hanson M; Gonzales E; Rauch J; Page L; McMichael TM; Keating R; Marx GE; Andrews T; Schmit K; Morris SB; Dowling NF; Peacock G;
    MMWR Morb Mortal Wkly Rep; 2020 May; 69(17):521-522. PubMed ID: 32352957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Disease 2019 (COVID-19) Prevalences Among People Experiencing Homelessness and Homelessness Service Staff During Early Community Transmission in Atlanta, Georgia, April-May 2020.
    Yoon JC; Montgomery MP; Buff AM; Boyd AT; Jamison C; Hernandez A; Schmit K; Shah S; Ajoku S; Holland DP; Prieto J; Smith S; Swancutt MA; Turner K; Andrews T; Flowers K; Wells A; Marchman C; Laney E; Bixler D; Cavanaugh S; Flowers N; Gaffga N; Ko JY; Paulin HN; Weng MK; Mosites E; Morris SB
    Clin Infect Dis; 2021 Nov; 73(9):e2978-e2984. PubMed ID: 32898272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Outbreak Among Three Affiliated Homeless Service Sites - King County, Washington, 2020.
    Tobolowsky FA; Gonzales E; Self JL; Rao CY; Keating R; Marx GE; McMichael TM; Lukoff MD; Duchin JS; Huster K; Rauch J; McLendon H; Hanson M; Nichols D; Pogosjans S; Fagalde M; Lenahan J; Maier E; Whitney H; Sugg N; Chu H; Rogers J; Mosites E; Kay M
    MMWR Morb Mortal Wkly Rep; 2020 May; 69(17):523-526. PubMed ID: 32352954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four COVID-19 screening strategies to facilitate early case identification within the homeless shelter population: A structured summary of a study protocol for a randomised controlled trial.
    O'Shea T; Mbuagbaw L; Mokashi V; Bulir D; Gilchrist J; Smieja N; Chong S; Marttala S; Vera V; Cvetkovic A; Smieja M
    Trials; 2020 Nov; 21(1):941. PubMed ID: 33225995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic.
    Baggett TP; Scott JA; Le MH; Shebl FM; Panella C; Losina E; Flanagan C; Gaeta JM; Neilan A; Hyle EP; Mohareb A; Reddy KP; Siedner MJ; Harling G; Weinstein MC; Ciaranello A; Kazemian P; Freedberg KA
    JAMA Netw Open; 2020 Dec; 3(12):e2028195. PubMed ID: 33351082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring for COVID-19 by universal testing in a homeless shelter in Germany: a prospective feasibility cohort study.
    Lindner AK; Sarma N; Rust LM; Hellmund T; Krasovski-Nikiforovs S; Wintel M; Klaes SM; Hoerig M; Monert S; Schwarzer R; Edelmann A; Martinez GE; Mockenhaupt FP; Kurth T; Seybold J
    BMC Infect Dis; 2021 Dec; 21(1):1241. PubMed ID: 34895157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission Dynamics of Large Coronavirus Disease Outbreak in Homeless Shelter, Chicago, Illinois, USA, 2020.
    Chang YS; Mayer S; Davis ES; Figueroa E; Leo P; Finn PW; Perkins DL
    Emerg Infect Dis; 2022 Jan; 28(1):76-84. PubMed ID: 34856112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus Disease 2019 Outbreak in a San Francisco Homeless Shelter.
    Imbert E; Kinley PM; Scarborough A; Cawley C; Sankaran M; Cox SN; Kushel M; Stoltey J; Cohen S; Fuchs JD
    Clin Infect Dis; 2021 Jul; 73(2):324-327. PubMed ID: 32744615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in testing, diagnosis and outcome in SARS-CoV-2 infection across outbreak settings in the Greater Toronto Area, Canada: an observational study.
    Wang L; Ma H; Yiu KCY; Calzavara A; Landsman D; Luong L; Chan AK; Kustra R; Kwong JC; Boily MC; Hwang S; Straus S; Baral SD; Mishra S
    CMAJ Open; 2020; 8(4):E627-E636. PubMed ID: 33037070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons Learned through Implementing SARS-CoV-2 Testing and Isolation for People Experiencing Homelessness in Congregate Shelters.
    Scott E; Rowan S; Chandler K; Fisher A; Hill B; Hill J; Marx GE; Farrell E; Wendel K; Stella SA
    Prog Community Health Partnersh; 2022; 16(2S):13-22. PubMed ID: 35912653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homeless Shelter Characteristics and Prevalence of SARS-CoV-2.
    Karb R; Samuels E; Vanjani R; Trimbur C; Napoli A
    West J Emerg Med; 2020 Aug; 21(5):1048-1053. PubMed ID: 32970553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful implementation of managed alcohol programs in the San Francisco Bay Area during the COVID-19 crisis.
    Ristau J; Mehtani N; Gomez S; Nance M; Keller D; Surlyn C; Eveland J; Smith-Bernardin S
    Subst Abus; 2021; 42(2):140-147. PubMed ID: 33848451
    [No Abstract]   [Full Text] [Related]  

  • 17. Lower Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among People Experiencing Homelessness Tested in Outdoor Encampments Compared With Overnight Shelters: Denver, Colorado, June-July 2020.
    Rowan SE; McCormick DW; Wendel KA; Scott T; Chavez-van de Hey J; Wilcox K; Stella SA; Kamis K; Burman WJ; Marx GE
    Clin Infect Dis; 2022 Aug; 75(1):e157-e164. PubMed ID: 35040947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2 antibodies among homeless people living rough, in shelters and squats: A large population-based study in France.
    Loubiere S; Monfardini E; Allaria C; Mosnier M; Allibert A; Ninove L; Bosetti T; Farnarier C; Hamouda I; Auquier P; Mosnier E; Tinland A
    PLoS One; 2021; 16(9):e0255498. PubMed ID: 34525096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shelter Characteristics, Infection Prevention Practices, and Universal Testing for SARS-CoV-2 at Homeless Shelters in 7 US Urban Areas.
    Self JL; Montgomery MP; Toews KA; Samuels EA; Imbert E; McMichael TM; Marx GE; Lohff C; Andrews T; Ghinai I; Mosites E;
    Am J Public Health; 2021 May; 111(5):854-859. PubMed ID: 33734836
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2 screening among people living in homeless shelters in Brussels, Belgium.
    Roland M; Ben Abdelhafidh L; Déom V; Vanbiervliet F; Coppieters Y; Racapé J
    PLoS One; 2021; 16(6):e0252886. PubMed ID: 34129635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.